A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine
Clinical trial NCT03755427 · COMPLETED
Trial details
- NCT number
- NCT03755427
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-10
- Primary completion
- 2019-01-05
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.